复发宫颈癌再次放疗

doi:10.3760/cma.j.issn.1673-422X.2015.02.020

摘要/Abstract

摘要： 盆腔脏器切除术是照射野内复发宫颈癌的首选治疗，但伴随着较高的死亡率并丧失盆腔脏器结构和功能。三维近距离治疗及立体定向体部放疗应用于照射野内复发宫颈癌再次放疗，提供了与盆腔脏器切除术相似的疗效、可接受的毒性反应以及保留脏器功能的机会。

关键词: 宫颈肿瘤, 近距离放射疗法, 放射外科手术, 再次放疗

Abstract: Pelvic exenteration, first line salvage therapy for selected recurrent cervical cancer patients, is accompanied by a high operative mortality and loss of structure and function of pelvic organs. Advances in radiation therapy, especially 3dimensional brachytherapy and stereotactic body radiotherapy, provide the opportunity to achieve similar efficacy of pelvic exenteration with acceptable complications and protect the structure and function of pelvic organs.

Key words: Uterine cervical neoplasms, Brachytherapy, Radiosurgery, Reirradiation

张翔,俞华. 复发宫颈癌再次放疗[J]. 国际肿瘤学杂志, 2015, 42(2): 153-156.

Zhang Xiang, Yu Hua. Reirradiation of recurrent cervical cancer[J]. Journal of International Oncology, 2015, 42(2): 153-156.

参考文献

［1］ Zanagnolo V, Minig LA, Gadducci A, et al. Surveillance procedures for patients for cervical carcinoma: a review of the literature［J］. Int J Gynecol Cancer, 2009, 19(3): 306-313. ［2］ Dimopoulos JC, Lang S, Kirisits C, et al. Dosevolume histogram parameters and local tumor control in magnetic resonance imageguided cervical cancer brachytherapy［J］. Int J Radiat Oncol Biol Phys, 2009, 75(1): 56-63. ［3］ Peiretti M, Zapardiel I, Zanagnolo V, et al. Management of recurrent cervical cancer: a review of the literature［J］. Surg Oncol, 2012, 21(2): e59-66. ［4］ Potter R, HaieMeder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (Ⅱ): concepts and terms in 3D imagebased treatment planning in cervix cancer brachytherapy3D dose volume parameters and aspects of 3D imagebased anatomy, radiation physics, radiobiology［J］. Radiother Oncol, 2006, 78(1): 67-77. ［5］ HaieMeder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GECESTRO Working Group (Ⅰ): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV［J］. Radiother Oncol, 2005, 74(3): 235-245. ［6］ Hellebust TP, Kirisits C, Berger D, et al. Recommendations from Gynaecological (GYN) GECESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D imagebased treatment planning of cervix cancer brachytherapy［J］. Radiother Oncol, 2010, 96(2): 153-160. ［7］ Murakami N, Kasamatsu T, Sumi M, et al. Vaginal tolerance of CT based imageguided highdose rate interstitial brachytherapy for gynecological malignancies［J］. Radiat Oncol, 2014, 9(1): 31. ［8］ Yoshida K, Yamazaki H, Nakamura S, et al. Reirradiation using interstitial brachytherapy increases vaginal mucosal reaction compared to initial brachytherapy in patients with gynecological cancer［J］. Anticancer Res, 2013, 33(12): 5687-5692. ［9］ ZolciakSiwinska A, Bijok M, JonskaGmyrek J, et al. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: Analysis of efficacy and dosage delivered to organs at risk［J］. Gynecol Oncol, 2014, 132(1): 93-97. ［10］ Abusaris H, Hoogeman M, Nuyttens JJ. Reirradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region［J］. Technol Cancer Res Treat, 2012, 11(6): 591-597. ［11］ Mabuchi S, Takahashi R, Isohashi F, et al. Reirradiation using highdoserate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience［J］. Int J Gynecol Cancer, 2014, 24(1): 141-148. ［12］ MartinezMonge R, Cambeiro M, RodriguezRuiz ME, et al. Phase Ⅱ trial of imagebased highdoserate interstitial brachytherapy for previously irradiated gynecologic cancer［J］. Brachytherapy, 2014, 13(3): 219-224. ［13］ Badakh DK, Grover AH. Reirradiation with highdoserate remote afterloading brachytherapy implant in patients with locally recurrent or residual cervical carcinoma［J］. J Cancer Res Ther, 2009, 5(1): 24-30. ［14］ Xiang EW, Shumo C, Yaqin D, et al. Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: an analysis of 73 cases［J］. Gynecol Oncol, 1998, 69(2): 125-129. ［15］ Mahantshetty U, Kalyani N, Engineer R, et al. Reirradiation using highdoserate brachytherapy in recurrent carcinoma of uterine cervix［J］. Brachytherapy, 2014, In press. ［16］ Brabham JG, Cardenes HR. Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience［J］. Am J Clin Oncol, 2009, 32(4): 417-422. ［17］ Nguyen PL, Devlin PM, Beard CJ, et al. Highdoserate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature［J］. Brachytherapy, 2013, 12(1): 77-83. ［18］ Kishi K, Sonomura T, Shirai S, et al. Critical organ preservation in reirradiation brachytherapy by injectable spacer［J］. Int J Radiat Oncol Biol Phys, 2009, 75(2): 587-594. ［19］ Viswanathan AN, Damato AL, Nguyen PL. Novel use of a hydrogel spacer permits reirradiation in otherwise incurable recurrent gynecologic cancers［J］. J Clin Oncol, 2013, 31(34): e446-447. ［20］ Dewas S, Bibault JE, Mirabel X, et al. Robotic imageguided reirradiation of lateral pelvic recurrences: preliminary results［J］. Radiat Oncol, 2011, 6: 77. ［21］ Guckenberger M, Bachmann J, Wulf J, et al. Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer［J］. Radiother Oncol, 2010, 94(1): 53-59. ［22］ Deodato F, Macchia G, Grimaldi L, et al. Stereotactic radiotherapy in recurrent gynecological cancer: a case series［J］. Oncol Rep, 2009, 22(2): 415-419.

[1]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.
[2]	张露, 蒋华, 林州, 马辰莺, 徐晓婷, 王利利, 周菊英. 免疫检查点抑制剂治疗复发转移性宫颈癌的疗效及预后分析[J]. 国际肿瘤学杂志, 2023, 50(8): 475-483.
[3]	吕璐, 孙鹏飞. 肠道菌群与宫颈癌[J]. 国际肿瘤学杂志, 2023, 50(6): 373-376.
[4]	赵永瑞, 高莹, 陈怡东, 徐建堃. 基于直线加速器的分次立体定向放疗对小体积脑转移瘤的有效性及安全性[J]. 国际肿瘤学杂志, 2023, 50(3): 138-143.
[5]	段传菊, 陈真云, 李晓红, 牛洪朋, 李秀敏. 复发宫颈癌免疫治疗1例[J]. 国际肿瘤学杂志, 2023, 50(12): 766-768.
[6]	马雪艳, 鲁历历, 孙鹏飞. 免疫微环境在宫颈癌中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(1): 47-50.
[7]	张露, 周菊英, 马辰莺, 林州. 复发转移性宫颈癌免疫治疗相关进展[J]. 国际肿瘤学杂志, 2022, 49(9): 517-520.
[8]	史英侠, 胡莉钧, 于静萍. 免疫检查点抑制剂在复发或转移性宫颈癌治疗中的应用[J]. 国际肿瘤学杂志, 2022, 49(9): 568-571.
[9]	彭琛, 谢印通, 张昕, 谢鹏. 宫颈癌维持治疗研究进展[J]. 国际肿瘤学杂志, 2022, 49(7): 430-435.
[10]	熊婵, 阎英, 谢晓冬, 孟繁杰, 于卉影. 辐射诱导的多倍体宫颈癌HeLa细胞生物学特性研究[J]. 国际肿瘤学杂志, 2022, 49(5): 263-269.
[11]	袁晨阳, 周菊英. 宫颈癌预后因素的研究进展[J]. 国际肿瘤学杂志, 2022, 49(5): 307-313.
[12]	袁晨阳, 周菊英, 杜霄, 纪环, 赵天翼. 宫颈癌2018与2009 FIGO分期的比较及预后因素分析[J]. 国际肿瘤学杂志, 2022, 49(3): 151-163.
[13]	杨文博, 肖丽, 毕建强, 孙云川. ¹⁹²Ir近距离放疗联合外照射及胆道支架治疗不能手术切除的肝门部胆管癌的应用探索[J]. 国际肿瘤学杂志, 2022, 49(2): 95-99.
[14]	王玥, 吴琼, 许愿, 龚唯, 徐晓婷. 老年宫颈癌的筛查与治疗进展[J]. 国际肿瘤学杂志, 2022, 49(12): 754-758.
[15]	杜霄, 周菊英. 局限性前列腺癌的立体定向放疗[J]. 国际肿瘤学杂志, 2021, 48(5): 313-316.